<HTML>
<HEAD>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=windows-1252">
<META NAME="Generator" CONTENT="Microsoft Word 97">
<META NAME="Template" CONTENT="C:\Program Files\Microsoft Office\Templates\HRS.dot">
</HEAD>
<BODY>

<FONT FACE="Courier New"><P>&#9;<B>[§346-345]  Special fund.  </B>(a)  There is established within the state treasury to be administered by the department, the state pharmacy assistance program special fund, into which shall be deposited:</P><DIR>
<DIR>
<DIR>
<DIR>

<P>&#9;(1)&#9;All moneys received from manufacturers that pay rebates as provided in section 346-342(g);</P>
<P>&#9;(2)&#9;Appropriations made by the legislature to the fund; and </P></DIR>
</DIR>
</DIR>
</DIR>

<P>&#9;(3)&#9;Any other revenues designated for the fund.</P>
<P>&#9;(b)  Moneys in the state pharmacy assistance program special fund may be used for:</P><DIR>
<DIR>
<DIR>
<DIR>

<P>&#9;(1)&#9;Reimbursement payments to participating pharmacies for co-payments required under the federal medicare part D pharmacy benefit program as provided to state pharmacy assistance program participants;</P>
<P>&#9;(2)&#9;The costs of administering the state pharmacy assistance program, including salary and benefits of employees, computer costs, and contracted services as provided in section 346-342(d); and </P>
<P>&#9;(3)&#9;Any other purpose deemed necessary by the department for the purpose of operating and administering the state pharmacy [assistance] program.</P></DIR>
</DIR>
</DIR>
</DIR>

<P>&#9;All interest on special fund balances shall accrue to the special fund.  Upon dissolution of the state pharmacy assistance program special fund, any unencumbered moneys in the fund shall lapse to the general fund.</P>
<B><P>&#9;</B>(c)  The department shall expend all revenues received from rebates paid by pharmaceutical manufacturers pursuant to section 346-342(g) to pay for the benefits to enrollees in the state pharmacy assistance program, the costs of administering the program, and reimbursement of medicaid pharmaceutical costs. [L 2005, c 209, pt of §2]</P>

<P>&nbsp;</P>
<P>&nbsp;</P></FONT></BODY>
</HTML>
<center><table border="0" width="90%"><tr>
<td align="left"><a href="/hrscurrent/Vol07_Ch0346-0398/HRS0346/HRS_0346-0344.HTM">Previous</a></td>
<td align="center"><a href=/hrscurrent/Vol07_Ch0346-0398>Vol07_Ch0346-0398</a></td>
<td align="right"><a href="/hrscurrent/Vol07_Ch0346-0398/HRS0346/HRS_0346-0346.HTM">Next</a></td>
</tr></table></center>
